Filing Details
- Accession Number:
- 0000899243-21-032613
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-11 19:49:17
- Reporting Period:
- 2021-08-10
- Accepted Time:
- 2021-08-11 19:49:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1325879 | Aveo Pharmaceuticals Inc. | AVEO | Pharmaceutical Preparations (2834) | 043581650 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1853186 | Michael Ferraresso | C/O Aveo Pharmaceuticals, Inc. 30 Winter Street Boston MA 02108 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-08-10 | 2,608 | $5.75 | 8,318 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes 2,426 shares acquired under AVEO's 2010 Employee Stock Purchase Plan.